Pregled bibliografske jedinice broj: 915787
Postprandial hypotension in neurological disorders: systematic review and meta-analysis
Postprandial hypotension in neurological disorders: systematic review and meta-analysis // Clinical autonomic research, 27 (2017), 4; 263-271 doi:10.1007/s10286-017-0440-8 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 915787 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Postprandial hypotension in neurological disorders: systematic review and meta-analysis
Autori
Pavelić, Antun ; Krbot Skorić, Magdalena ; Crnošija, Luka ; Habek, Mario
Izvornik
Clinical autonomic research (0959-9851) 27
(2017), 4;
263-271
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Autonomic nervous system ; Meta-analysis ; Neurological diseases ; Postprandial hypotension ; Systematic review
Sažetak
Postprandial hypotension (PPH) has been associated with increased risk of syncope, falls, stroke, angina and mortality. As the majority of patients with PPH are asymptomatic, the diagnosis is often overlooked. The aim of this study was to perform a systematic review and meta-analysis of available scientific evidence on the likelihood of PPH in neurological diseases. A systematic review of the literature (PubMed library, Cochrane Database for Systematic Reviews and Cochrane Central Register of Controlled Trials for results up to January 2017) identified 327 studies, of which 11 reported the frequency of PPH in patients with neurological diseases compared to healthy controls. These 11 studies were on patients with Parkinson's disease (PD ; n = 6 studies), multiple system atrophy (MSA ; n = 1), Alzheimer's disease (AD ; n = 1) and diabetic neuropathy (DN ; n = 2). The meta-analysis revealed that patients with neurological diseases had a significantly higher frequency of PPH than healthy controls [147/289 patients vs. 41/217 controls ; odd ratio (OR) 5.23, 95% confidence interval (CI) 2.90-9.45, p < 0.00001]. For each of the four diseases, the respective patients had a significantly higher frequency of PPH than healthy controls (PD: 107/201 patients vs. 32/136 controls ; OR 3.49, 95% CI 2.09-5.83, p < 0.0001 ; MSA: 19/27 patients vs. 0/24 controls ; OR 89.55, 95% CI 2.65-3030.33, p = 0.01 ; AD: 7/10 patients vs. 6/23 controls ; OR 6.61, 95% CI 1.28-34.14, p = 0.02 ; DN: 14/51 patients vs. 3/34 controls ; OR 4.83, 95%CI 1.20-19.41, p = 0.03). The likelihood of having PPH is higher in patients with neurological diseases than in healthy controls. These findings should prompt further research focusing on the epidemiology and pathophysiology of PPH in different neurological diseases.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Interdisciplinarne biotehničke znanosti
POVEZANOST RADA
Ustanove:
Fakultet elektrotehnike i računarstva, Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE